3 / 4
Page 8
Notes:
Journal of Neurology and Clinical Neuroscience | Volume: 03
8
th
International Conference on
NEUROLOGICAL DISORDERS,
CENTRAL NERVOUS SYSTEM AND STROKE
&
International Conference on
NEUROLOGY AND NEUROSURGERY
December 04-05, Dubai, UAE
Joint event on
J Neurol Clin Neurosci, Volume: 03
E
veryday Painful Peripheral Neuropathy (PPN) causes
hundreds of millions of people around the world
to suffer in torment and discomfort. While multiple
meta-analyses and systematic reviews document that
pharmacologic agents help these patients better than
placebos some also state that our current treatments are
“inadequate” “frustrating and maybe even appalling”.
These results may be due in part to the concept that
“patients with neuropathy have irreversible nerve
damage.” The continued search for an effective drug to
treat PPN has yet to be found.
Albert Einstein’s insight that “we can’t solve problems by
using the same kind of thinking we used when we created
them” suggests that searching for a better drug may not
be successful. His colleague, Erwin Schrodinger offered
an alternative when he stated, “life at a cellular level is
quantum mechanics; pure physics and pure chemistry.”
In the 1980’s Becker used animal models to show that
electromagnetic energy fields induce limb regeneration.
More recently cell culture experiments have documented
the effects of electrical stimulation on the myelinization of
dorsal root ganglion cells.
These animal models lead Drs. Odell and Sorgnard to
develop Electronic Cell Signal Treatment (EST). EST
combines and simultaneously delivers Frequency-
Modulated (FM) and Amplitude-Modulated (AM) electric
cell currents in a pulsed electromagnetic field. Using local
anesthetics to block pain and other nerve functions creates
CET (Combined Electrochemical Treatment.)
The use EST and CET have allowed Drs. Odell, Sorgnard,
Cernak and others to show how the principles of physics
regenerate nerves, reduce pain, restore function and have
no side effects. These results dramatically improve the
lives of patients suffering from PPN.
In producing these results, EST and CET transform the
treatment of PPN and usher in a new way of treating pain.
Biography
Peter M Carney received his B.A. in 1958 from Williams College and his
MD in 1962 fromWestern Reserve School of Medicine. In 1962 he started
at the Yale-New Haven Hospital as a surgical intern and left in 1968 as
a neurosurgeon. He became a diplomate of the American Board of
Neurological Surgeons in 1971. He has taught neurosurgery at Tufts-New
England Medical Center, been Chairman of the Department of Surgery at
the King Faisal Specialist Hospital in Riyadh, Saudi Arabia, and since 1985
has been in private practice in Elkhart, Indiana.
Since his residency at Yale he has sought ways to transform the practice of
medicine, helping in 1966 to establish the use of the operating microscope
in neurosurgery. In 1996 his presentation at the AANS meeting helped
improve the treatment of acute subdural hematomas. Since 2011 he has
actively advocated using CET to help patients with neuropathy.
e:
pmcegh@aol.comPeter M Carney
Private practice, USA
Physics treats Neuropathy better than Pharmacolgy